Neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514 · see citing works

The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders

Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280 · see citing works

An Assessment of Oxidative Damage to Proteins, Lipids, and DNA in Brain from Patients with Alzheimer's Disease

Lyras, L., Cairns, N. J., Jenner, A., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052061.x · Cited by 531 · see citing works

Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease

Wang, J., Xiong, S., Xie, C., Markesbery, W. R., & Lovell, M. A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03053.x · Cited by 452 · see citing works

Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase and PKB signaling

Schreibelt, G., Kooij, G., Reijerkerk, A., van Doorn, R., Gringhuis, S. I., van der Pol, S., Weksler, B. B., Romero, I. A., Couraud, P., Piontek, J., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8329com · Cited by 347 · see citing works

RAGE‐dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease

Fang, F., Lue, L.-F., Yan, S., Xu, H., Luddy, J. S., Chen, D., Walker, D. G., Stern, D. M., Yan, S., Schmidt, A. M., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-139634 · Cited by 335 · see citing works

Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy

Carrano, A., Hoozemans, J. J. M., van der Vies, S. M., Rozemuller, A. J. M., van Horssen, J., & de Vries, H. E. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3895 · Cited by 293 · see citing works

Reactive oxygen species mediate Rac-induced loss of cell-cell adhesion in primary human endothelial cells

van Wetering, S., van Buul, J. D., Quik, S., Mul, E. P. J., Anthony, E. C., ten Klooster, J. P., Collard, J. G., & Hordijk, P. L. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.9.1837 · Cited by 278 · see citing works

Neuroinflammation in Alzheimer's Disease: Mechanisms, Pathologic Consequences, and Potential for Therapeutic Manipulation

Hensley, K. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1414 · Cited by 250 · see citing works

Amyloid β‐Peptide Induces Cell Monolayer Albumin Permeability, Impairs Glucose Transport, and Induces Apoptosis in Vascular Endothelial Cells

Blanc, E. M., Toborek, M. J., Mark, R. J., Hennig, B., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68051870.x · Cited by 174 · see citing works

Amyloid β-peptide1–42 alters tight junction protein distribution and expression in brain microvessel endothelial cells

Marco, S., & Skaper, S. D. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.03.047 · Cited by 172 · see citing works

Microglia, amyloid and dementia in Alzheimer disease

Arends, Y. M., Duyckaerts, C., Rozemuller, J. M., Eikelenboom, P., & Hauw, J.-J. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00094-4 · Cited by 139 · see citing works

Amyloid-β-induced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation

Tai, L. M., Holloway, K., Male, D. K., Loughlin, J., & Romero, I. A. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00717.x · Cited by 115 · see citing works

The Neuroinflammatory Response in Plaques and Amyloid Angiopathy in Alzheimers Disease: Therapeutic Implications

Rozemuller, A. M., van Gool, W. A., & Eikelenboom, P. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007054038229 · Cited by 98 · see citing works

Characteristics of Dyshoric Capillary Cerebral Amyloid Angiopathy

Richard, E., Carrano, A., Hoozemans, J. J., van Horssen, J., van Haastert, E. S., Eurelings, L. S., de Vries, H. E., Thal, D. R., Eikelenboom, P., van Gool, W. A., et al. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181fab558 · Cited by 71 · see citing works

Soluble aggregates of the amyloid‐β protein selectively stimulate permeability in human brain microvascular endothelial monolayers

Gonzalez‐Velasquez, F. J., Kotarek, J. A., & Moss, M. A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05618.x · Cited by 65 · see citing works

ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease

Simpson, D. S. A., & Oliver, P. L. (2020) · Antioxidants · doi:10.3390/antiox9080743 · Cited by 1,044 · see citing works

Functional morphology of the blood–brain barrier in health and disease

Liebner, S., Dijkhuizen, R. M., Reiss, Y., Plate, K. H., Agalliu, D., & Constantin, G. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1815-1 · Cited by 872 · see citing works

The blood-brain barrier in Alzheimer’s disease

Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767 · see citing works

Interaction between Aβ and Tau in the Pathogenesis of Alzheimer’s Disease

Zhang, H., Wei, W., Zhao, M., Ma, L., Jiang, X., Pei, H., Cao, Y., & Li, H. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.57078 · Cited by 689 · see citing works

Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer’s Disease

Yamazaki, Y., & Kanekiyo, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091965 · Cited by 451 · see citing works

Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders

Lochhead, J. J., Yang, J., Ronaldson, P. T., & Davis, T. P. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00914 · Cited by 445 · see citing works

NADPH oxidase in brain injury and neurodegenerative disorders

Ma, M. W., Wang, J., Zhang, Q., Wang, R., Dhandapani, K. M., Vadlamudi, R. K., & Brann, D. W. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0150-7 · Cited by 432 · see citing works

Neuroinflammation in frontotemporal dementia

Bright, F., Werry, E. L., Dobson-Stone, C., Piguet, O., Ittner, L. M., Halliday, G. M., Hodges, J. R., Kiernan, M. C., Loy, C. T., Kassiou, M., et al. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0231-z · Cited by 280 · see citing works

New insight into neurological degeneration: Inflammatory cytokines and blood–brain barrier

Yang, J., Ran, M., Li, H., Lin, Y., Ma, K., Yang, Y., Fu, X., & Yang, S. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1013933 · Cited by 291 · see citing works

Barrier function in the peripheral and central nervous system—a review

Reinhold, A., & Rittner, H. L. (2016) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-016-1920-8 · Cited by 279 · see citing works

Neuroinflammation in Alzheimer’s disease

Zhang, F., & Jiang, L. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s75546 · Cited by 276 · see citing works

Endothelial dysfunction: molecular mechanisms and clinical implications

Wang, X., & He, B. (2024) · MedComm · doi:10.1002/mco2.651 · Cited by 292 · see citing works

Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles

Tijms, B. M., Vromen, E. M., Mjaavatten, O., Holstege, H. H., Reus, L. M., van der Lee, S. J., Wesenhagen, K. E. J., Lorenzini, L., Vermunt, L., Venkatraghavan, V., et al. (2024) · Nature Aging · doi:10.1038/s43587-023-00550-7 · Cited by 222 · see citing works

Selective loss of cortical endothelial tight junction proteins during Alzheimer’s disease progression

Yamazaki, Y., Shinohara, M., Shinohara, M., Yamazaki, A., Murray, M. E., Liesinger, A. M., Heckman, M. G., Lesser, E. R., Parisi, J. E., Petersen, R. C., et al. (2019) · Brain · doi:10.1093/brain/awz011 · Cited by 202 · see citing works

Cellular and molecular mechanisms of the blood–brain barrier dysfunction in neurodegenerative diseases

Chen, T., Dai, Y., Hu, C., Lin, Z., Wang, S., Yang, J., Zeng, L., Li, S., & Li, W. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00557-1 · Cited by 201 · see citing works

The <i>APOE</i> ε4/ε4 Genotype Potentiates Vascular Fibrin(Ogen) Deposition in Amyloid-Laden Vessels in the Brains of Alzheimer's Disease Patients

Hultman, K., Strickland, S., & Norris, E. H. (2013) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1038/jcbfm.2013.76 · Cited by 183 · see citing works

Reactive astrocytes: The nexus of pathological and clinical hallmarks of Alzheimer’s disease

Price, B. R., Johnson, L. A., & Norris, C. M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101335 · Cited by 174 · see citing works

Vascular contributions to Alzheimer's disease

Eisenmenger, L. B., Peret, A., Famakin, B. M., Spahic, A., Roberts, G. S., Bockholt, J. H., Johnson, K. M., & Paulsen, J. S. (2022) · Translational research · doi:10.1016/j.trsl.2022.12.003 · Cited by 179 · see citing works

Diabetes and Hypercholesterolemia Increase Blood-Brain Barrier Permeability and Brain Amyloid Deposition: Beneficial Effects of the LpPLA2 Inhibitor Darapladib

Acharya, N. K., Levin, E. C., Clifford, P. M., Han, M. C., Tourtellotte, R., Chamberlain, D., Pollaro, M., Coretti, N. J., Kosciuk, M. C., Nagele, E. P., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122254 · Cited by 140 · see citing works

Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer’s disease and vascular cognitive impairment

Skike, C. E. V., Jahrling, J. B., Dorigatti, A. O., Sayre, N. L., Hussong, S. A., Ungvari, Z. I., Lechleiter, J. D., & Galván, V. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00570.2017 · Cited by 140 · see citing works

The Neurovascular Unit Dysfunction in Alzheimer’s Disease

Soto-Rojas, L. O., Pacheco‐Herrero, M., Martínez-Gómez, P. A., Campa-Córdoba, B. B., Apátiga-Pérez, R., Villegas-Rojas, M. M., Harrington, C. R., de la Cruz, F., Garcés‐Ramírez, L., & Luna‐Muñoz, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042022 · Cited by 140 · see citing works

Common pathways in dementia and diabetic retinopathy: understanding the mechanisms of diabetes-related cognitive decline

Little, K., Llorián‐Salvador, M., Scullion, S., Hernández, C., Simó‐Servat, O., del Marco, À., Bosma, E. K., Vargas-Soria, M., Carranza-Naval, M. J., Bergen, T. V., et al. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.10.008 · Cited by 136 · see citing works

Pathological changes within the cerebral vasculature in Alzheimer’s disease: New perspectives

Fisher, R. A., Miners, J. S., & Love, S. (2022) · Brain Pathology · doi:10.1111/bpa.13061 · Cited by 127 · see citing works

Blood-brain barrier receptors and transporters: an insight on their function and how to exploit them through nanotechnology

Moura, R. P., Martins, C., Pinto, S. F. T., Sousa, F., & Sarmento, B. F. C. C. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1583205 · Cited by 127 · see citing works

Blood-brain barrier dysfunction and Alzheimer’s disease: associations, pathogenic mechanisms, and therapeutic potential

Chen, Y., He, Y., Han, J., Wei, W., & Chen, F. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1258640 · Cited by 116 · see citing works

Inflammatory events at blood–brain barrier in neuroinflammatory and neurodegenerative disorders: Implications for clinical disease

de Vries, H. E., Kooij, G., Frenkel, D., Georgopoulos, S., Monsonego, A., & Janigro, D. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03702.x · Cited by 113 · see citing works

Oxidative stress, redox signalling and endothelial dysfunction in ageing‐related neurodegenerative diseases: a role of NADPH oxidase 2

Cahill‐Smith, S., & Li, J. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12357 · Cited by 106 · see citing works

Physiology and Clinical Relevance of Enlarged Perivascular Spaces in the Aging Brain

Bown, C. W., Carare, R. O., Schrag, M., & Jefferson, A. L. (2021) · Neurology · doi:10.1212/wnl.0000000000013077 · Cited by 106 · see citing works

Multiple roles of short-chain fatty acids in Alzheimer disease

Chen, H., Meng, L., & Shen, L. (2021) · Nutrition · doi:10.1016/j.nut.2021.111499 · Cited by 107 · see citing works

Cerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy?

Silva, T. M. D., & Miller, A. A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00061 · Cited by 104 · see citing works

Luteolin Inhibits Fibrillary β-Amyloid1–40-Induced Inflammation in a Human Blood-Brain Barrier Model by Suppressing the p38 MAPK-Mediated NF-κB Signaling Pathways

Zhang, J., Xing, J., Wang, L., Jiang, H., Guo, S., & Liu, R. (2017) · Molecules · doi:10.3390/molecules22030334 · Cited by 101 · see citing works

The Blood–Brain Barrier and Its Intercellular Junctions in Age-Related Brain Disorders

Costea, L., Mészáros, Á., Bauer, H., Bauer, H., Traweger, A., Wilhelm, I., Farkas, A. E., & Krizbai, I. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215472 · Cited by 98 · see citing works

C-Reactive Protein Predicts Hematoma Growth in Intracerebral Hemorrhage

Napoli, M. D., Parry‐Jones, A., Smith, C. J., Hopkins, S. J., SLEVIN, M. A., Masotti, L., Campi, V., Singh, P., Papa, F., Popa‐Wagner, A., et al. (2013) · Stroke · doi:10.1161/strokeaha.113.001721 · Cited by 94 · see citing works

The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier

Magaki, S., Tang, Z., Tung, S., Williams, C. K., Lo, D., Yong, W. H., Khanlou, N., & Vinters, H. V. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.004 · Cited by 93 · see citing works

Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer’s disease pathology

Rosenberger, A. F. N., Morrema, T. H. J., Gerritsen, W. H., van Haastert, E. S., Snkhchyan, H., Hilhorst, R., Rozemüller, A. J. M., Scheltens, P., van der Vies, S. M., & Hoozemans, J. J. M. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0470-x · Cited by 93 · see citing works

Microglia and the Blood–Brain Barrier: An External Player in Acute and Chronic Neuroinflammatory Conditions

Gullotta, G. S., Costantino, G., Sortino, M. A., & Spampinato, S. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119144 · Cited by 90 · see citing works

Understanding the Pathophysiology of Cerebral Amyloid Angiopathy

Gatti, L., Tinelli, F., Scelzo, E., Arioli, F., Fede, G. D., Obici, L. P., Pantoni, L., Giaccone, G., Caroppo, P., Parati, E. A., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103435 · Cited by 91 · see citing works

Sex differences in the blood–brain barrier and neurodegenerative diseases

Weber, C. M., & Clyne, A. M. (2021) · APL Bioengineering · doi:10.1063/5.0035610 · Cited by 91 · see citing works

Interactions between glial cells and the blood-brain barrier and their role in Alzheimer's disease

Zhao, M., Jiang, X., Zhang, H., Sun, J., Pei, H., Ma, L., Cao, Y., & Li, H. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101483 · Cited by 85 · see citing works

Ferroptosis and Iron Homeostasis: Molecular Mechanisms and Neurodegenerative Disease Implications

Abdukarimov, N., Kokabi, K., & Kunz, J. (2025) · Antioxidants · doi:10.3390/antiox14050527 · Cited by 83 · see citing works

Brain Regulation of Thrombosis and Hemostasis

Fisher, M. (2013) · Stroke · doi:10.1161/strokeaha.113.000736 · Cited by 82 · see citing works

The blood–brain and gut–vascular barriers: from the perspective of claudins

Scalise, A. A., Kakogiannos, N., Zanardi, F., Iannelli, F., & Giannotta, M. (2021) · Tissue Barriers · doi:10.1080/21688370.2021.1926190 · Cited by 84 · see citing works

The role of neutrophils in the dysfunction of central nervous system barriers

Santos-Lima, B., Pietronigro, E. C., Terrabuio, E., Zenaro, E., & Constantin, G. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.965169 · Cited by 82 · see citing works

Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders

Batarseh, Y. S., Duong, Q.-V., Mousa, Y. M., Rihani, S. B. A., Elfakhri, K. H., & Kaddoumi, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030338 · Cited by 80 · see citing works

Vascular cognitive impairment – Past, present, and future challenges

Badji, A., Youwakim, J., Cooper, A., Westman, E., & Marseglia, A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102042 · Cited by 81 · see citing works

Lychee seed polyphenol protects the blood–brain barrier through inhibiting Aβ(25–35)‐induced NLRP3 inflammasome activation via the AMPK / mTOR / ULK1‐mediated autophagy in bEnd .3 cells and APP / PS1 mice

Xiong, R., Zhou, X., Tang, Y., Wu, J., Sun, Y., Teng, J., Pan, R., Law, B. Y. K., Zhao, Y., Qiu, W., et al. (2020) · Phytotherapy Research · doi:10.1002/ptr.6849 · Cited by 78 · see citing works

The microcirculation, the blood-brain barrier, and the neurovascular unit in health and Alzheimer disease: The aberrant pericyte is a central player

Divecha, Y. A., Rampes, S., Tromp, S., Boyanova, S., Fleckney, A. L., Fidanboylu, M., & Thomas, S. A. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100052 · Cited by 79 · see citing works

The impact of neuroinflammation on neuronal integrity

Tastan, B., & Heneka, M. T. (2024) · Immunological Reviews · doi:10.1111/imr.13419 · Cited by 77 · see citing works

Vessel-Associated Immune Cells in Cerebrovascular Diseases: From Perivascular Macrophages to Vessel-Associated Microglia

Koizumi, T., Kerkhofs, D., Mizuno, T., Steinbusch, H. W. M., & Foulquier, S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01291 · Cited by 73 · see citing works

Establishing Co-Culture Blood–Brain Barrier Models for Different Neurodegeneration Conditions to Understand Its Effect on BBB Integrity

Park, J. S., Choe, K., Khan, A., Jo, M. H., Park, H. Y., Kang, M. H., Park, T. J., & Kim, M. O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065283 · Cited by 72 · see citing works

Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer’s disease

Shi, H., Koronyo, Y., Fuchs, D.-T. S., Sheyn, J., Wawrowsky, K., Lahiri, S., Black, K. L., & Koronyo‐Hamaoui, M. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01076-4 · Cited by 70 · see citing works

Immune responses at brain barriers and implications for brain development and neurological function in later life

Stolp, H. B., Liddelow, S. A., Sá-Pereira, I., Dzięgielewska, K. M., & Saunders, N. R. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00061 · Cited by 67 · see citing works

Annexin A1 restores cerebrovascular integrity concomitant with reduced amyloid-β and tau pathology

Ries, M., Watts, H. R., Mota, B. C., Lopez, M. Y., Donat, C. K., Baxan, N., Pickering, J. A., Chau, T. W., Semmler, A., Gurung, B., et al. (2021) · Brain · doi:10.1093/brain/awab050 · Cited by 66 · see citing works

Trafficking of immune cells across the blood-brain barrier is modulated by neurofibrillary pathology in tauopathies

Majerová, P., Michalicová, A., Cente, M., Hanes, J., Vegh, J., Kittel, Á., Kosikova, N., Cigánková, V., Mihaljević, S., Jadhav, S., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217216 · Cited by 67 · see citing works

Current Status and Challenges Associated with CNS-Targeted Gene Delivery across the BBB

Kimura, S., & Harashima, H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121216 · Cited by 64 · see citing works

Mechanobiology of the blood-brain barrier during development, disease and ageing

Konig, S., Jayarajan, V., Wray, S., Kamm, R. D., & Moeendarbary, E. (2025) · Nature Communications · doi:10.1038/s41467-025-61888-7 · Cited by 70 · see citing works

Cerebral Amyloid Angiopathy and Blood-Brain Barrier Dysfunction

Gireud, M., Mack, A. F., McCullough, L. D., & Urayama, A. (2020) · The Neuroscientist · doi:10.1177/1073858420954811 · Cited by 61 · see citing works

Mechanistic insights and emerging therapeutic stratagems for Alzheimer’s disease

Rajendran, K., & Krishnan, U. M. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102309 · Cited by 58 · see citing works

Retinal arterial Aβ40 deposition is linked with tight junction loss and cerebral amyloid angiopathy in MCI and AD patients

Shi, H., Koronyo, Y., Fuchs, D.-T. S., Sheyn, J., Jallow, O., Mandalia, K., Graham, S. L., Gupta, V., Mirzaei, M., Kramerov, A. A., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13086 · Cited by 54 · see citing works

Aβ1–42 oligomer induces alteration of tight junction scaffold proteins via RAGE-mediated autophagy in bEnd.3 cells

Chan, Y., Chen, W., Wan, W., Chen, Y., Li, Y., & Zhang, C. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.05.025 · Cited by 54 · see citing works

Alzheimer’s Risk Gene TREM2 Determines Functional Properties of New Type of Human iPSC-Derived Microglia

Reich, M., Paris, I., Ebeling, M., Dahm, N., Schweitzer, C., Reinhardt, D., Schmucki, R., Prasad, M. K., Köchl, F., Leist, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.617860 · Cited by 54 · see citing works

Inflammation: major denominator of obesity, Type 2 diabetes and Alzheimer’s disease-like pathology?

Kacířová, M., Zmeškalová, A., Kořínková, L., Železná, B., Kuneš, J., & Maletı́nská, L. (2020) · Clinical Science · doi:10.1042/cs20191313 · Cited by 53 · see citing works

The Neurovascular Protective Effects of Huperzine A on D-Galactose-Induced Inflammatory Damage in the Rat Hippocampus

Ruan, Q., Hu, X., Ao, H., Ma, H., Gao, Z., Liu, F., Kong, D., Bao, Z., & Yu, Z. (2014) · Gerontology · doi:10.1159/000358235 · Cited by 52 · see citing works

Manual acupuncture benignly regulates blood-brain barrier disruption and reduces lipopolysaccharide loading and systemic inflammation, possibly by adjusting the gut microbiota

Zhang, Y., Ding, N., Hao, X., Zhao, J., Zhao, Y., Li, Y., & Li, Z. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1018371 · Cited by 52 · see citing works

ATP-binding cassette transporters P-glycoprotein and breast cancer related protein are reduced in capillary cerebral amyloid angiopathy

Carrano, A., Snkhchyan, H., Kooij, G., van der Pol, S., van Horssen, J., Veerhuis, R., Hoozemans, J., Rozemuller, A., & de Vries, H. E. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.015 · Cited by 51 · see citing works

Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles

Islam, Y., Leach, A. G., Smith, J. A., Pluchino, S., Coxon, C. R., Sivakumaran, M., Downing, J. R., Fatokun, A. A., Teixidò, M., & Ehtezazi, T. (2021) · Advanced Science · doi:10.1002/advs.202002085 · Cited by 51 · see citing works

Multifunctional Effect of Human Serum Albumin Reduces Alzheimer’s Disease Related Pathologies in the 3xTg Mouse Model

Ezra, A., Rabinovich-Nikitin, I., Rabinovich‐Toidman, P., & Solomon, B. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150694 · Cited by 50 · see citing works

Effects of acute and chronic oxidative stress on the blood–brain barrier in 2D and 3D in vitro models

Chung, T. D., Linville, R. M., Guo, Z., Ye, R., Jha, R., Grifno, G. N., & Searson, P. C. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00327-x · Cited by 49 · see citing works

Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell Damage

Takeuchi, M., Sakai, A., Takata, T., Takino, J.-I., Koriyama, Y., Kikuchi, C., Furukawa, A., Nagamine, K., Hori, T., & Matsunaga, T. (2021) · Biomolecules · doi:10.3390/biom11030387 · Cited by 49 · see citing works

Designing and optimizing AAV-mediated gene therapy for neurodegenerative diseases: from bench to bedside

Xu, L., Yao, S., Ding, Y. E., Xie, M., Feng, D., Sha, P., Tan, L., Bei, F., & Yao, Y. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05661-2 · Cited by 48 · see citing works

Amyloid-β Interacts with Blood-Brain Barrier Function in Dementia: A Systematic Review

Burgmans, S., van de Haar, H. J., Verhey, F. R. J., & Backes, W. H. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122155 · Cited by 47 · see citing works

Angiopoietin like-4 as a novel vascular mediator in capillary cerebral amyloid angiopathy

Chakraborty, A., Kamermans, A., Hof, B. V. H., Castricum, K. C. M., Aanhane, E., van Horssen, J., Thijssen, V. L., Scheltens, P., Teunissen, C. E., Fontijn, R. D., et al. (2018) · Brain · doi:10.1093/brain/awy274 · Cited by 46 · see citing works

Aging Neurovascular Unit and Potential Role of DNA Damage and Repair in Combating Vascular and Neurodegenerative Disorders

Li, Y., Xie, L., Huang, T., Zhang, Y., Zhou, J., Qi, B., Wang, X., Chen, Z., & Li, P. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00778 · Cited by 46 · see citing works

Blood-Brain Barrier Dysfunction in Small Vessel Disease Related Intracerebral Hemorrhage

Freeze, W. M., Jacobs, H. I. L., Schreuder, F. H. B. M., van Oostenbrugge, R. J., Backes, W. H., Verhey, F. R. J., & Klijn, C. J. M. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00926 · Cited by 45 · see citing works

Plasma soluble TREM2 is associated with white matter lesions independent of amyloid and tau

Tsai, H.-H. C., Chen, Y., Yen, R., Lo, Y.-L., Yang, K., Jeng, J., Tsai, L., & Chang, C.-F. (2021) · Brain · doi:10.1093/brain/awab332 · Cited by 45 · see citing works

Dysfunction of the Blood-brain Barrier in Cerebral Microbleeds: from Bedside to Bench

Wang, H., Zhang, C., Qiu, Y., Chen, A., Li, Y., & Hu, B. (2021) · Aging and Disease · doi:10.14336/ad.2021.0514 · Cited by 47 · see citing works

Implication of type 4 NADPH oxidase (NOX4) in tauopathy

Luengo, E., Trigo-Alonso, P., Fernández‐Mendívil, C., Núñez, Á., del Campo, M., Porrero, C., García‐Magro, N., Negredo, P., Senar, S., Sánchez‐Ramos, C., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.redox.2021.102210 · Cited by 42 · see citing works

Altered blood–brain barrier transport in neuro-inflammatory disorders

Schenk, G. J., & de Vries, H. E. (2016) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2016.07.002 · Cited by 42 · see citing works

Blood–brain barrier dysfunction in mice induced by lipopolysaccharide is attenuated by dapsone

Zhou, T., Zhao, L., Zhan, R., He, Q., Tong, Y., Tian, X., Wang, H., Zhang, T., Fu, Y., Sun, Y., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.09.093 · Cited by 41 · see citing works

Crossing borders in Alzheimer’s disease: A T cell’s perspective

van Olst, L., Coenen, L., Nieuwland, J. M., Rodriguez-Mogeda, C., de Wit, N. M., Kamermans, A., Middeldorp, J., & de Vries, H. E. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114398 · Cited by 44 · see citing works

The Role of Sphingolipids and Specialized Pro-Resolving Mediators in Alzheimer’s Disease

de Wit, N. M., Mol, K., Rodríguez‐Lorenzo, S., de Vries, H. E., & Kooij, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.620348 · Cited by 39 · see citing works

Insoluble Vascular Amyloid Deposits Trigger Disruption of the Neurovascular Unit in Alzheimer’s Disease Brains

Soto-Rojas, L. O., Campa-Córdoba, B. B., Harrington, C. R., Salas‐Casas, A., Hernándes‐Alejandro, M., Villanueva‐Fierro, I., Bravo-Muñoz, M., Garcés‐Ramírez, L., de la Cruz‐López, F., Ontiveros‐Torres, M. Á., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073654 · Cited by 39 · see citing works

Occludin deficiency with BACE1 elevation in cerebral amyloid angiopathy

Cheng, X., He, P., Yao, H., Dong, Q., Li, R., & Shen, Y. (2014) · Neurology · doi:10.1212/wnl.0000000000000403 · Cited by 39 · see citing works

Fibronectin induces the perivascular deposition of cerebrospinal fluid–derived amyloid-β in aging and after stroke

Howe, M. D., Atadja, L. A., Furr, J. W., Maniskas, M. E., Zhu, L., McCullough, L. D., & Urayama, A. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.07.019 · Cited by 38 · see citing works

Single Mild Traumatic Brain Injury Induces Persistent Disruption of the Blood-Brain Barrier, Neuroinflammation and Cognitive Decline in Hypertensive Rats

Szarka, N., Tóth, L., Czigler, A., Kellermayer, Z., Ungvari, Z., Amrein, K., Czeiter, E., Bali, Z. K., Tadepalli, S. A., Wahr, M., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133223 · Cited by 31 · see citing works

Blood-brain barrier dysfunction as a potential therapeutic target for neurodegenerative disorders

Uprety, A. R., Kang, Y., & Kim, S. Y. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01332-8 · Cited by 38 · see citing works

Neuroprotective effect of 1-Deoxynojirimycin on cognitive impairment, β-amyloid deposition, and neuroinflammation in the SAMP8 mice

Chen, W., Liang, T., Zuo, W.-W., Wu, X., Shen, Z.-B., Wang, F., Li, C., Zheng, Y., & Peng, G. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.106 · Cited by 37 · see citing works

cAMP Compartmentalization in Cerebrovascular Endothelial Cells: New Therapeutic Opportunities in Alzheimer’s Disease

Viña, D., Seoane, N., Vasquez, E. C., & Campos‐Toimil, M. (2021) · Cells · doi:10.3390/cells10081951 · Cited by 39 · see citing works

TRA2A-induced upregulation of LINC00662 regulates blood-brain barrier permeability by affecting ELK4 mRNA stability in Alzheimer’s microenvironment

Liu, Q., Zhu, L., Liu, X., Zheng, J., Liu, Y., Ruan, X., Cao, S., Cai, H., Li, Z., & Xue, Y. (2020) · RNA Biology · doi:10.1080/15476286.2020.1756055 · Cited by 33 · see citing works

SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer’s Disease

Unzeta, M., Hernández‐Guillamón, M., Sun, P., & Solé, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073365 · Cited by 33 · see citing works

Statins Inhibit Fibrillary β-Amyloid Induced Inflammation in a Model of the Human Blood Brain Barrier

Griffin, J. M., Kho, D. T., Graham, E. S., Nicholson, L. F. B., & O’Carroll, S. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157483 · Cited by 32 · see citing works

The relationship between TGF-β1 and cognitive function in the brain

Su, C., Miao, J., & Guo, J. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110820 · Cited by 32 · see citing works

Protein markers of cerebrovascular disruption of neurovascular unit: immunohistochemical and imaging approaches

Amtul, Z., & Hepburn, J. D. (2014) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0041 · Cited by 30 · see citing works

Alzheimer’s disease: The role of T lymphocytes in neuroinflammation and neurodegeneration

Asamu, M. O., Oladipo, O. O., Abayomi, O. A., & Adebayo, A. A. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148589 · Cited by 31 · see citing works

Vascular Endothelial Growth Factor remains unchanged in cerebrospinal fluid of patients with Alzheimer’s disease and vascular dementia

Chakraborty, A., Chatterjee, M., Twaalfhoven, H. A. M., del Campo, M., Teunissen, C. E., Scheltens, P., Fontijn, R. D., van der Flier, W. M., & de Vries, H. E. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0385-8 · Cited by 30 · see citing works

Clearance of interstitial fluid (ISF) and CSF (CLIC) group‐part of Vascular Professional Interest Area (PIA), updates in 2022‐2023. Cerebrovascular disease and the failure of elimination of Amyloid‐β from the brain and retina with age and Alzheimer's disease: Opportunities for therapy

Kelly, L., Brown, C., Michalik, D., Hawkes, C. A., Aldea, R., Agarwal, N., Salib, R. J., Alzetani, A., Ethell, D. W., Counts, S., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13512 · Cited by 30 · see citing works

Deep learning assisted quantitative assessment of histopathological markers of Alzheimer’s disease and cerebral amyloid angiopathy

Perosa, V., Scherlek, A. A., Kozberg, M. G., Smith, L. A., Westerling, T., Auger, C. A., Vasylechko, S., Greenberg, S. M., & van Veluw, S. J. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01235-1 · Cited by 29 · see citing works

Development of Cerebral Microbleeds in the APP23-Transgenic Mouse Model of Cerebral Amyloid Angiopathy—A 9.4 Tesla MRI Study

Reuter, B., Venus, A., Heiler, P. M., Schad, L. R., Ebert, A., Hennerici, M. G., Grudzenski, S., & Fatar, M. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00170 · Cited by 27 · see citing works

Imaging the neurovascular unit in health and neurodegeneration: a scoping review of interdependencies between MRI measures

Rowsthorn, E., Pham, W., Nazem‐Zadeh, M., Law, M., Pase, M. P., & Harding, I. H. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00499-0 · Cited by 28 · see citing works

Novel therapeutic opportunities for neurodegenerative diseases with mesenchymal stem cells: the focus on modulating the blood-brain barrier

Vargas-Rodríguez, P., Cuenca-Martagón, A., Castillo-González, J., Serrano-Martínez, I., Luque, R. M., Delgado, M., & González-Rey, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814117 · Cited by 25 · see citing works

Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy

Carrano, A., Hoozemans, J. J. M., van der Vies, S. M., Rozemuller, A. J. M., van Horssen, J., & de Vries, H. E. (2011) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2011.3895 · Cited by 293 · see citing works

P2‐263: Oxidative stress and tight junctions alterations in capillary cerebral amyloid angiopathy

Carrano, A., van Horssen, J., de Vries, H. E., & Rozemüller, A. J. M. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.05.1313

The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier

Magaki, S., Tang, Z., Tung, S., Williams, C. K., Lo, D., Yong, W. H., Khanlou, N., & Vinters, H. V. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.004 · Cited by 93 · see citing works

Amyloid-β Contributes to Blood–Brain Barrier Leakage in Transgenic Human Amyloid Precursor Protein Mice and in Humans With Cerebral Amyloid Angiopathy

Hartz, A. M. S., Bauer, B., Soldner, E. L. B., Wolf, A., Boy, S., Backhaus, R., Mihaljevic, I., Bogdahn, U., Klünemann, H. H., Schuierer, G., et al. (2012) · Stroke · doi:10.1161/strokeaha.111.627562 · Cited by 248 · see citing works

Brain endothelial dysfunction in AD

de Vries, H. E. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.059640 · Cited by 1 · see citing works